Model systems for studying the blood-brain barrier: Applications and challenges

Area of Science:

• Neuroscience
• Pharmacology
• Biomedical Engineering

Background:

• The blood-brain barrier (BBB) restricts the passage of therapeutic agents into the central nervous system (CNS).
• BBB complexity involves a physical barrier and active efflux pumps, hindering drug delivery.
• Understanding BBB dynamics is crucial for developing effective CNS treatments.

Purpose of the Study:

• To review existing in vitro and in vivo blood-brain barrier (BBB) model systems.
• To evaluate the strengths and limitations of current BBB models for studying drug permeability and CNS diseases.
• To highlight the need for advanced models that better mimic BBB dynamics for clinical applications.

Main Methods:

• Review of in vitro models assessing endothelial cell permeability and transporter roles.
• Analysis of in vivo animal models for real-time drug permeability and CNS changes.
• Evaluation of communication between BBB cells and the microenvironment.

Main Results:

• Current BBB models offer insights into endothelial permeability, efflux transporter function, and cell-environment interactions.
• In vivo models allow examination of dynamic BBB changes and treatment responses in disease states.
• Each model system possesses distinct advantages and disadvantages for physiological and pathological studies.

Conclusions:

• Existing blood-brain barrier (BBB) models provide valuable tools for understanding CNS drug delivery.
• There is a continuous need for innovative BBB models that more accurately reflect dynamic physiological conditions.
• Improved BBB models are essential for advancing the clinical application of CNS therapies.